R Ohno - Concepedia

Author

R Ohno

Nagoya University ORCID

Also Known As

K Takahashi , K Takatsuki, R OHNO, R Ohno, R. OHNO, R. Ohno, RYUZO OHNO, Rinka Ohno, Ryuji Ohno, Ryuzo Ohno

173

Publications

8.2K

Citations

H-Index

Concepts

All Affiliations

Nagoya University Hamamatsu University School of Medicine Aichi Cancer Center Nagasaki University Nagoya University Hospital

About

R Ohno is an author at Nagoya University specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	33	5.7K
2	Immunology	15	17	1.4K
3	Health Sciences	12	12	3.4K
4	Cell Biology	8	8	356
5	Emergency Medicine	1	1	99

R Ohno

Publications

7.7K

Citations

H-Index

Page 1

	Year	Citations
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia Bruce D. Cheson, John M. Bennett, Thomas Büchner, Journal of Clinical Oncology Mixed-phenotype Acute LeukemiaPathologyAcute LeukemiaResponse CriteriaHematological Malignancy	2003	2.6K
Efficacy and safety of recombinant human soluble thrombomodulin (ART‐123) in disseminated intravascular coagulation: results of a phase III, randomized, double‐blind clinical trial Hiroaki Saito, Ikuro Maruyama, S Shimazaki, Journal of Thrombosis and Haemostasis ThrombosisCardiovascular DiseaseMedicinePhase IiiHematology	2006	594
Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product Hitoshi Kiyoi, Masayuki Towatari, Shohei Yokota, Leukemia Flt3 GeneDevelopmental BiologyGenetic DisorderGeneticsGenomic Mechanism	1998	446
Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia Hitoshi Kiyoi, T Naoe, S Yokota, Leukemia Hematological MalignancyMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyImmunology	1997	342
Establishment of a novel human megakaryoblastic leukemia cell line, MEG- 01, with positive Philadelphia chromosome Michinori Ogura, Y Morishima, R Ohno, Blood	1985	322
An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma. R Ohno, Kosuke Okada, T Masaoka, Journal of Clinical Oncology Hematological MalignancyTumor BiologyLymphoid NeoplasiaOncologyRefractory Cases	1990	229
Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group. Norio Asou, Koichi Adachi, Jun‐ichi Tamura, Journal of Clinical Oncology	1998	208
Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study Jin Takeuchi, Taiichi Kyo, K Naito, Leukemia Hematological MalignancyLymphoid NeoplasiaIntensive ConsolidationOncologyHealth Sciences	2002	188
A randomized trial comparing interferon-alpha with busulfan for newly diagnosed chronic myelogenous leukemia in chronic phase Kazunori Ohnishi, R Ohno, Masao Tomonaga, Blood	1995	188
Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines Kensuke Naito, Akihiro Takeshita, Kohichiro Shigeno, Leukemia Hematological MalignancyCytocidal EffectP-glycoprotein-expressing SublinesMedicineHematology	2000	152

Page 1